Antiviral Activities of Algal-Based Sulfated Polysaccharides

Molecules. 2022 Feb 9;27(4):1178. doi: 10.3390/molecules27041178.

Abstract

An antiviral agent is urgently needed based on the high probability of the emergence and re-emergence of future viral disease, highlighted by the recent global COVID-19 pandemic. The emergence may be seen in the discovery of the Alpha, Beta, Gamma, Delta, and recently discovered Omicron variants of SARS-CoV-2. The need for strategies besides testing and isolation, social distancing, and vaccine development is clear. One of the strategies includes searching for an antiviral agent that provides effective results without toxicity, which is well-presented by significant results for carrageenan nasal spray in providing efficacy against human coronavirus-infected patients. As the primary producer of sulfated polysaccharides, marine plants, including macro- and microalgae, offer versatility in culture, production, and post-isolation development in obtaining the needed antiviral agent. Therefore, this review will describe an attempt to highlight the search for practical and safe antiviral agents from algal-based sulfated polysaccharides and to unveil their features for future development.

Keywords: antiviral agents; macroalgae; microalgae; sulfated polysaccharides.

Publication types

  • Review

MeSH terms

  • Antiviral Agents* / chemistry
  • Antiviral Agents* / therapeutic use
  • COVID-19 / epidemiology
  • COVID-19 / therapy*
  • Humans
  • Microalgae / chemistry*
  • Pandemics*
  • Polysaccharides* / chemistry
  • Polysaccharides* / therapeutic use
  • SARS-CoV-2*

Substances

  • Antiviral Agents
  • Polysaccharides

Supplementary concepts

  • SARS-CoV-2 variants